Infants and children aged <2 years are strongly recommended to receive MenB vaccine
All infants and children aged <2 years are strongly recommended to receive MenB vaccine. Bexsero is the only MenB vaccine that can be used in infants and children aged <10 years.
The number of doses required depends on the age of the child when they start the vaccine course.
Table. Recommendations for immunisation of infants and children aged <2 years using meningococcal B vaccine
Medical conditions are specified in List. Specified medical conditions associated with increased risk of invasive meningococcal disease.
| Age at start of vaccine course | MenB vaccine brand | Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease) |
|---|---|---|
|
6 weeks to 5 months |
Bexsero |
3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later) |
|
6–11 months |
Bexsero |
3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later) |
|
12–23 months |
Bexsero |
2 doses (8 weeks between doses) |
Related diseases
Page history
Last updated
Last reviewed